In accordance with some embodiments of the invention there is provided an acoustic mirror (200, 600, 700, 800), including an ultrasound beam deflecting surface (306) and a base couplable to an ultrasound catheter (102) comprising an ultrasound beam emitting surface (104). When the acoustic mirror is mounted on the ultrasound catheter the deflecting surface is angled in relation to ultrasound beam emitting surface and configured to (i) at least partially interfere with a path of propagation of an ultrasound beam mitted from the emitting surface and (ii) deflect the ultrasound beam impinging on the deflecting surface. Other embodiments are also described.

Systems and methods can include wearable, non-invasive ultrasound modalities for treating a variety of medical conditions, including but not limited to peripheral vascular disease. The modality could be therapeutic ultrasound (TUS), and be configured to promote angiogenesis within a patient via stimulation of cavitation and shear stress, among other mechanisms.

The present disclosure provides an ultrasonic transducer and a focused ultrasound treatment device. The ultrasonic transducer includes a sound generation unit and a sound emitting surface, the sound emitting surface being a spherical surface having a first notch, a second notch and a third notch, wherein one great circle of a sphere corresponding to the sound emitting surface is a main great circle, the first notch and the second notch are respectively positioned at two intersections of the spherical surface and a diameter perpendicular to the main great circle, and the third notch connects the first notch with the second notch; each cross-section of the sound emitting surface parallel to the main great circle is in a shape of an arc; and the ultrasonic wave generated by the sound generation unit is focused on a center of the sphere corresponding to the sound emitting surface.

Apparatus is provided for ablating cardiac tissue of a subject. The apparatus comprises an inflatable element, configured to be transthoracically placed within a pericardial region of the subject and a reflection-facilitation element, configured to deliver a fluid to the pericardial region, such that a portion of the fluid is disposed within the inflatable element, and another portion of the fluid is disposed outside of the inflatable element and inside the pericardial region. The apparatus additionally comprises at least one ultrasound transducer, configured to be transcatheterally placed in a heart chamber of the subject, and to apply ultrasound energy such that at least a portion of the applied energy is reflected by the fluid. Other embodiments are also described.

Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.

A method of treating an infected implant by administering acoustic shock waves to an implant area or region encompassing an implantation, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the implant area to acoustic shock waves stimulating the implant area or region. The emitted acoustic shock waves are focused or unfocused acoustic shock waves, or acoustic pressure waves, generated electrohydraulically, electromagnetically, radially, or via a piezo electric generating system.

An improved system and method of endobronchial imaging of lung nodules comprises the introduction of a perfluorocarbon (PFC) liquid into pulmonary passages of the lungs, the introduction of which enables better coupling between an endobronchial ultrasonic imaging system and a target tissue site within the pulmonary passages of the lungs, the improved coupling between the ultrasonic imaging system and a target tissue site being imparted by the removal (at least in part) the air interface present between the ultrasonic imaging system and the surface of the target tissue site. Furthermore, the unique properties of perfluorocarbon liquids (for example, the properties of superb biocompatibility, high affinity for dissolving oxygen, and extremely low surface tension) further position these substances to be particularly well-suited for this application.

The present disclosure provides an extracorporeal focused ultrasound treatment device for a pelvic disease. The treatment device includes an ultrasonic transducer and a treatment couch. Sound emitting surface of the ultrasonic transducer is a spherical surface having a first notch, a second notch and a third notch, the first notch and the second notch are respectively positioned at two intersections of the spherical surface and a diameter perpendicular to the main great circle, and the third notch connects the first notch with the second notch; a cross-section of the sound emitting surface parallel to the main great circle is in a shape of an arc; and an ultrasonic wave generated by the sound generation unit is focused at a center of the sphere corresponding to the sound emitting surface. The treatment couch is configured for a human body to lie in a lithotomy position.

A method of modulating glandular secretions by administering acoustic shock waves to a reflexology zone has been discovered. In one preferred embodiment, a treatment method achieves one or more of a) modulating blood sugar levels, b) stimulating insulin production levels or c) normalizing A1C levels by administering acoustic shock waves to a reflexology zone or region of a patient. The treatment method further has the steps of: activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves; subjecting the reflexology zone to acoustic shock waves stimulating the pancreas to have a modulated response wherein the modulated response is one of an adjustment in blood sugar levels or insulin production and release or normalizing A1C levels which increases low level output, decreases high level output or stabilizes erratic output; and wherein the emitted acoustic shock waves are focused or unfocused.

A phacoemulsification apparatus includes an ultrasound transmitter, an irrigation-aspiration tool, a robotic arm, and a processor. The ultrasound transmitter is configured to generate and focus an ultrasound beam into a lens capsule of an eye of a patient, to emulsify a lens of the eye. The irrigation-aspiration tool having a distal end including an outlet of an irrigation channel for flowing irrigation fluid into the lens capsule, and an inlet of an aspiration channel for removing material from the lens capsule. The robotic arm is configured to move the distal end of the irrigation-aspiration tool inside the lens capsule. The processor is configured to control the ultrasound transmitter to irradiate one or more target locations in the eye capsule with the focused ultrasound beam, and control the robotic arm to move the distal end of the irrigation-aspiration tool in coordination with the target locations irradiated by the ultrasound transmitter.